These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30296922)

  • 1. Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists.
    Girdhar K; Dehury B; Kumar Singh M; Daniel VP; Choubey A; Dogra S; Kumar S; Mondal P
    J Biomol Struct Dyn; 2019 Sep; 37(15):3976-3986. PubMed ID: 30296922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
    J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Frimann TM; Ko SK; Harris P; Bukrinski JT; Peters GHJ
    J Biomol Struct Dyn; 2023 Jul; 41(11):5007-5021. PubMed ID: 35612899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.
    Dods RL; Donnelly D
    Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ECD conformational transition mechanism of GLP-1R by molecular dynamics simulations and Markov state model.
    Zhang J; Bai Q; Pérez-Sánchez H; Shang S; An X; Yao X
    Phys Chem Chem Phys; 2019 Apr; 21(16):8470-8481. PubMed ID: 30957116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
    Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
    J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency.
    Wang X; Yun Y; Chen L; Guo S; Niu B; Fang J; Yuan Q; Shen J; Xie X; Wang K
    Bioorg Med Chem; 2024 Jun; 107():117761. PubMed ID: 38795571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
    Willard FS; Ho JD; Sloop KW
    Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
    Gómez Santiago C; Paci E; Donnelly D
    Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.
    Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D
    Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design.
    Longwell CK; Hanna S; Hartrampf N; Sperberg RAP; Huang PS; Pentelute BL; Cochran JR
    ACS Chem Biol; 2021 Jan; 16(1):58-66. PubMed ID: 33307682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes.
    Zhang X; Belousoff MJ; Liang YL; Danev R; Sexton PM; Wootten D
    Cell Rep; 2021 Jul; 36(2):109374. PubMed ID: 34260945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists.
    Lin F; Wang R
    J Mol Model; 2009 Jan; 15(1):53-65. PubMed ID: 18941807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Méndez M; Matter H; Defossa E; Kurz M; Lebreton S; Li Z; Lohmann M; Löhn M; Mors H; Podeschwa M; Rackelmann N; Riedel J; Safar P; Thorpe DS; Schäfer M; Weitz D; Breitschopf K
    J Med Chem; 2020 Mar; 63(5):2292-2307. PubMed ID: 31596080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
    Cheong YH; Kim MK; Son MH; Kaang BK
    Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Helix or β-Turn? An Investigation into N-Terminally Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4.
    Oddo A; Mortensen S; Thøgersen H; De Maria L; Hennen S; McGuire JN; Kofoed J; Linderoth L; Reedtz-Runge S
    Biochemistry; 2018 Jul; 57(28):4148-4154. PubMed ID: 29877701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding sites and design strategies for small molecule GLP-1R agonists.
    Zhang H; Wu T; Wu Y; Peng Y; Wei X; Lu T; Jiao Y
    Eur J Med Chem; 2024 Sep; 275():116632. PubMed ID: 38959726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.
    Bird GH; Fu A; Escudero S; Godes M; Opoku-Nsiah K; Wales TE; Cameron MD; Engen JR; Danial NN; Walensky LD
    ACS Chem Biol; 2020 Jun; 15(6):1340-1348. PubMed ID: 32348108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative binding site and SAR rationalization of small molecules against glucagon-like peptide-1 receptor using homology model and crystal structures: a comparative study.
    Thamaraiselvan V; Velayutham R
    J Biomol Struct Dyn; 2022 Mar; 40(5):2038-2052. PubMed ID: 33118484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.